Maybe you should reread my post. I said the judge can only rule on NCE but that does not preclude him from making comments about other matters between the FDA and amarin, which he is certainly aware of from doing his due diligence. Please review " the roles of federal district judges" in brook law for clarification. Also, this matter is being decided by a judge, not a jury so restraints that may be imposed on a jury are not necessarily imposed on a judge.
News 
Market Data 
Discover 
AI
